Kdoqi Disclaimer
American Journal of Kidney Diseases · 2006
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Kdoqi Disclaimer trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Kdoqi Disclaimer's perspective
Ordered by how strongly the researchers Kdoqi Disclaimer trusts endorse each paper. Same corpus, a different order for every researcher.
- A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTS (Transplantation)
- Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality (Annals of Internal Medicine)
- Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. (Blood)
- Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. (The Lancet)
- The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses
- Leg Muscle Mass and Composition in Relation to Lower Extremity Performance in Men and Women Aged 70 to 79: The Health, Aging and Body Composition Study (Journal of The American Geriatrics Society)
- Frailty in older adults: evidence for a phenotype. (The journals of gerontology. Series A, Biological sciences and medical sciences)
- Exploratory latent structure analysis using both identifiable and unidentifiable models
- Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. (Journal of applied physiology)
- Sarcopenia =/= dynapenia. (The journals of gerontology. Series A, Biological sciences and medical sciences)